Bicycle Therapeutics plc Debt Instrument, Basis Spread on Variable Rate
Bicycle Therapeutics plc (BCYC) had Debt Instrument, Basis Spread on Variable Rate of 4.55% as of 2020-09-30, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 · last filed 2026-03-17
- 2020-09-30: Debt Instrument, Basis Spread on Variable Rate 4.55%.
| Period end | Debt Instrument, Basis Spread on Variable Rate |
|---|---|
| 2020-09-30 | 4.55% 10-K · filed 2026-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |